David Taussig

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

Céline Berthon, Emmanuel Raffoux, Xavier Thomas et al. · The Lancet Haematology · 2016 · 425 citations

Hematological Malignancy, Translational Medicine, Acute Leukaemia +14

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

David Taussig · Blood · 2005 · 365 citations · Full text

Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

David Taussig, Farideh Miraki‐Moud, Fernando Anjos‐Afonso et al. · Blood · 2008 · 361 citations

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction

David Taussig, Jacques Vargaftig, Farideh Miraki‐Moud et al. · Blood · 2010 · 356 citations · Full text

Characterization of Cells with a High Aldehyde Dehydrogenase Activity from Cord Blood and Acute Myeloid Leukemia Samples

Daniel J. Pearce, David Taussig, Catherine Simpson et al. · Stem Cells · 2005 · 303 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Redox Biology +20